According to another recent study, the cell surface molecule KREMEN1 was verified as an entry receptor for CV-A1019, KREMEN1 overexpression enhances CV-A10 binding to the cell surface and increases susceptibility to infection, indicating that KREMEN1 is a rate-limiting factor for CV-A10 infection. Here, KREMEN1 is linked to infection.